Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Fe-doped polydopamine pickering emulsion as a nanoplatform for synergistic photothermal-ferroptosis immunotherapy in breast cancer

  1. 1Department of Breast Surgery, Changzhou Cancer Hospital (The Fourth People’s Hospital of Changzhou)
  2. 2School of Materials Science and Engineering, Changzhou University

Abstract

Introduction: Triple-negative breast cancer remains a formidable clinical challenge owing to its immunosuppressive microenvironment and inherently low immunogenicity.

Methods: To address this, we developed a multifunctional Pickering emulsion (Fe-PDA-PE-R837) stabilized by iron-doped polydopamine (Fe-PDA) nanoparticles, which function dually as photothermal agents and localized iron donors, while the soybean oil core encapsulates the immunoadjuvant R837. The Fe-PDA nanoparticles exhibited uniform spherical morphology, excellent colloidal stability, and a broad absorption band extending to the NIR region. Upon 808 nm laser irradiation, the Fe-PDA shell generates local hyperthermia with a photothermal conversion efficiency of 38.5%, disrupts intracellular iron homeostasis to provoke ferroptotic cell death, as evidenced by GSH depletion and MDA accumulation, while the stimuli-responsive release of R837 coupled with immunogenic cell death (ICD) elicits potent local and systemic pro-inflammatory responses.

Results: In vitro assays demonstrated that the combination treatment achieved ∼80% cell killing, markedly inhibited cell migration, and significantly upregulated TNF-α and IL-12 secretion. In vivo evaluation using the 4T1 murine breast cancer model confirmed that this nanoplatform significantly suppressed primary tumor growth and pulmonary metastasis, with no appreciable systemic toxicity.

Discussion: Collectively, this interfacial engineering strategy underscores the promising translational potential of Pickering emulsion-based nanoplatforms for aggressive solid tumor therapy.

Related

  1. An X-ray-activated nano-bio hybrid for synergistic radiotherapy/photothermal/immunotherapy of prostate cancer.
    Yizhao Xu, Tao Zhao, Zixuan Li +8
    Journal of nanobiotechnologyPeer-reviewedCC BY-NC-NDFull textSystems & synthetic biologyGeneral medicineEurope PMCDOAJPMC
  2. Nanofibers of polyester–polydopamine copolymers enable combined photothermal effect and chemotherapy for local cancer treatment
    Giuseppina Biscari, Alessia Lo Re, Calogero Fiorica +6
    International Journal of PharmaceuticsPeer-reviewedLicence not statedFull textPharmacology & toxicologyHAL
  3. NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds
    Yuqi Han, Kai Deng, Ruoqi Chen +5
    Materials Today BioPeer-reviewedCC BY-NCFull textGeneral medicineDOAJEurope PMCPMC
  4. Biomimetic mycobacterial dual spatiotemporal targeting induces trained immunity for tuberculosis photothermal immunotherapy and relapse prevention
    Wei Wang, Xiaoxue Li, Meijia Pan +6
    eBioMedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
  5. A tumor-responsive nanoplatform orchestrating multiplexed macrophage engagers and immune checkpoint blockade for triple-negative breast cancer immunotherapy
    Bo Xiang, Tao Liu, Wei Wang +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
BibTeX
@article{xu2026fedoped,
  title = {{Fe-doped polydopamine pickering emulsion as a nanoplatform for synergistic photothermal-ferroptosis immunotherapy in breast cancer}},
  author = {Ling-Yu Xu and Peng Zhang and Min-Jing Yu and Hao-Ran Li and Li-Chen Cao and Haiyan Gao},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.3389/fphar.2026.1956784},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1956784/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Fe-doped polydopamine pickering emulsion as a nanoplatform for synergistic photothermal-ferroptosis immunotherapy in breast cancer
AU  - Ling-Yu Xu
AU  - Peng Zhang
AU  - Min-Jing Yu
AU  - Hao-Ran Li
AU  - Li-Chen Cao
AU  - Haiyan Gao
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1956784
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1956784/full
AB  - Introduction: Triple-negative breast cancer remains a formidable clinical challenge owing to its immunosuppressive microenvironment and inherently low immunogenicity.  Methods: To address this, we developed a multifunctional Pickering emulsion (Fe-PDA-PE-R837) stabilized by iron-doped polydopamine (Fe-PDA) nanoparticles, which function dually as photothermal agents and localized iron donors, while the soybean oil core encapsulates the immunoadjuvant R837. The Fe-PDA nanoparticles exhibited uniform spherical morphology, excellent colloidal stability, and a broad absorption band extending to the NIR region. Upon 808 nm laser irradiation, the Fe-PDA shell generates local hyperthermia with a photothermal conversion efficiency of 38.5%, disrupts intracellular iron homeostasis to provoke ferroptotic cell death, as evidenced by GSH depletion and MDA accumulation, while the stimuli-responsive release of R837 coupled with immunogenic cell death (ICD) elicits potent local and systemic pro-inflammatory responses.  Results: In vitro assays demonstrated that the combination treatment achieved ∼80% cell killing, markedly inhibited cell migration, and significantly upregulated TNF-α and IL-12 secretion. In vivo evaluation using the 4T1 murine breast cancer model confirmed that this nanoplatform significantly suppressed primary tumor growth and pulmonary metastasis, with no appreciable systemic toxicity.  Discussion: Collectively, this interfacial engineering strategy underscores the promising translational potential of Pickering emulsion-based nanoplatforms for aggressive solid tumor therapy.
SN  - 1663-9812
ER  -